BlackRock’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.8M | Sell |
|
|||||
|
2025
Q1 | $20.8M | Sell |
|
|||||
|
2024
Q4 | $28.4M | Buy |
|
|||||
|
2024
Q3 | $56.5M | Buy |
|
|||||
|
2024
Q2 | $30.1M | Buy |
|
|||||
|
2024
Q1 | $29.2M | Buy |
|
|||||
|
2023
Q4 | $24.5M | Buy |
|
|||||
|
2023
Q3 | $25.3M | Buy |
|
|||||
|
2023
Q2 | $28.7M | Buy |
|
|||||
|
2023
Q1 | $11.7M | Sell |
|
|||||
|
2022
Q4 | $19M | Buy |
|
|||||
|
2022
Q3 | $17.1M | Sell |
|
|||||
|
2022
Q2 | $13.3M | Buy |
|
|||||
|
2022
Q1 | $18.8M | Sell |
|
|||||
|
2021
Q4 | $29M | Buy |
|
|||||
|
2021
Q3 | $38M | Buy |
|
|||||
|
2021
Q2 | $39.3M | Buy |
|
|||||
|
2021
Q1 | $30.6M | Buy |
|
|||||
|
2020
Q4 | $26.3M | Buy |
|
|||||
|
2020
Q3 | $26.3M | Sell |
|
|||||
|
2020
Q2 | $23.9M | Buy |
|
|||||
|
2020
Q1 | $15.1M | Sell |
|
|||||
|
2019
Q4 | $20M | Buy |
|